Long-term relapse-free survival in childhood acute nonlymphocytic leukemia.
D000208:Acute Disease; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects; D004224:Diterpenes; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D000084562:Retinyl Esters; D013866:Thioguanine / Q000008:administration & dosage; D014801:Vitamin A / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004224:Diterpenes; D000084562:Retinyl Esters; D003561:Cytarabine; D014801:Vitamin A; C014794:retinol palmitate; D004317:Doxorubicin; D013866:Thioguanine